The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7807210 B1

PDF
Full Text
Expired
Date of Patent:
Oct. 05, 2010

Filed:

Apr. 05, 2004
Applicants:

Wouter E. Roorda, Palo Alto, CA (US);

Niraj Shah, West New York, NJ (US);

André-jean Lundkvist, Santa Clara, CA (US);

Inventors:

Wouter E. Roorda, Palo Alto, CA (US);

Niraj Shah, West New York, NJ (US);

André-Jean Lundkvist, Santa Clara, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 33/00 (2006.01); A61L 33/10 (2006.01); A61F 2/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to providing a porous, hydrophobic polymer with a hemocompatible substance and to the materials produced thereby. One embodiment of the present invention relates to the providing of expanded poly(tetrafluoroethylene) with one or more complexes of heparin, typically containing heparin in combination with a hydrophobic counter ion. The hemocompatible substance is dissolved in a mixture of solvents in which a first solvent wets the polymer to be coated and the second solvent enhances the solubility of the hemocompatible substance material in the solvent mixture. Typical first solvents wetting hydrophobic polymers include non-polar such as hydrochlorofluorocarbons. Typical second solvents include polar solvents such as organic alcohols and ketones. Azeotropic mixtures of the second solvent in the first solvent are used in some embodiments of the present invention although second solvents may be employed in a range of concentration ranges from less than 0.1% up to saturation. A typical example providing a heparin complex to an endoluminal stent, consisting of coating DURAFLO onto an ePTFE stent-covering material.


Find Patent Forward Citations

Roorda, Wouter. (2010). Hemocompatible polymers on hydrophobic porous polymers (U.S. Patent No. 7807210). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7807210

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…